News

HDA UK Media and Political Bulletin – 24 February 2021

Media Summary

Number of UK COVID-19 vaccinations falls by a third as vaccine supply dips
The Guardian, Dan Sabbagh & Natalie Grover, 23 February

The Guardian reports that the number of COVID-19 vaccines administered in the UK has fallen by over a third in the last week as ministers warned of a short-term dip in supply, coupled with stockpiling to ensure people get second doses within the recommended 12-week limit.

The latest data showed 192,341 people received a first jab on Monday, the second-lowest daily total since 17 January – taking the number of people in Britain who have had an initial COVID-19 vaccination to 17.9 million. On Sunday the number of vaccinations was 141,719. Taken together, the total for the past two days is 35% lower than the equivalent figures last week.

Matt Hancock, the Health Secretary, said in a radio interview the country could expect “a quieter week this week” for vaccinations because of supply pressure but that the rollout would bounce back next month. “We’re going to have some really bumper weeks in March,” he added.

Nicola Sturgeon, Scotland’s First Minister, also said in her daily press briefing that there had been “a temporary dip,” but added there were other factors at play to suggest that UK vaccine stocks had been reduced. Other reasons for the slowdown, the First Minister said, included “the higher than expected uptake so far, and also the need to reserve stock so that second doses can be offered to people who received their first dose in December.”

 

Parliamentary Coverage

Dr June Raine appointed as CEO of MHRA
Department of Health and Social Care, 23 February

Dr June Raine has been appointed as the Medicines and Healthcare products Regulatory Agency’s (MHRA) new Chief Executive, having been the interim CEO since 2019.

Dr Raine played a crucial part in setting up rolling reviews during the pandemic to ensure the UK was the first in the world to authorise the Pfizer/BioNTech and Oxford University/AstraZeneca COVID-19 vaccines. Her work has helped improve patient safety and patient engagement and has helped establish the UK as a world-leading destination for life sciences.

Health Minister Lord Bethell said: “It is thanks to Dr Raine’s strong leadership during the pandemic that the UK was the first country in the world to authorise COVID-19 vaccines. The MHRA is widely regarded as one of the best regulators in the world with the highest standards of safety and I’m delighted to confirm Dr Raine’s appointment as CEO.”

You can read the full press release here.

 

House of Commons – Written Answer, 23 February

Sarah Owen (Labour, Luton North): To ask the Secretary of State for Health and Social Care, what preparations the Government is making with community pharmacies for the distribution of a COVID-19 vaccine.

Jo Churchill (Conservative, Bury St Edmunds): NHS England and NHS Improvement are working with all the national pharmacy organisations on plans to ensure that community pharmacies, including large chain pharmacies, are used to optimal effect in the COVID-19 vaccination programme, starting with the sites that can do this at scale. As of 22 February 2021, 196 community pharmacies have now started to offer the COVID-19 vaccination service, with more pharmacies joining the service over the coming weeks. We expect 200 community pharmacies sites to offer the COVID-19 vaccination service as of 8 March 2021. Some pharmacists and members of their team have also been working with general practitioners to deliver the vaccine in many areas of the country.

 

Northern Ireland Assembly, Written Question, 22 February

Paula Bradshaw (Alliance, South Belfast): To ask the Minister of Health, given that community pharmacy is not mentioned in any detail in the document referred to, for an update on the detail of the precise role to be played by community pharmacists during the vaccination roll-out.

 

Full Coverage

Number of UK COVID-19 vaccinations falls by a third as vaccine supply dips
The Guardian, Dan Sabbagh & Natalie Grover, 23 February

The number of COVID-19 vaccines administered in the UK has fallen by over a third in the last week as ministers warned of a short-term dip in supply coupled with stockpiling to ensure people get second doses within the recommended 12-week limit.

The latest data showed 192,341 people received a first jab on Monday, the second-lowest daily total since 17 January – taking the number of people in Britain who have had an initial COVID-19 vaccination to 17.9 million.

On Sunday the number of vaccinations was 141,719, the lowest figure since the UK daily count began on 10 January. Taken together, the total for the past two days is 35% lower than the equivalent figures last week.

Matt Hancock, the Health Secretary, said in a radio interview the country could expect “a quieter week this week” for vaccinations because of supply pressure but that the rollout would bounce back next month. “We’re going to have some really bumper weeks in March.”

Nicola Sturgeon, Scotland’s First Minister, also said in her daily press briefing that there had been “a temporary dip”, but added there were other factors at play to suggest that UK vaccine stocks had been reduced.

Other reasons for the slowdown, the first minister said, included “the higher than expected uptake so far, and also the need to reserve stock so that second doses can be offered to people who received their first dose in December”.

UK ministers have repeatedly said they expect supplies to be uneven, particularly while Pfizer reduces production at its European plant in Belgium during February to increase the amount it can make in March. AstraZeneca has promised to produce an average of 2m doses a week, but it acknowledges its production can be lumpy.

Modelling documents released by the Scientific Advisory Group for Emergencies (Sage) on Monday also appear to suggest that the UK could speed up its pace of inoculation towards the end of March.

A document from Sage’s modelling subcommittee produced earlier this month suggests that vaccinations could potentially be carried out at the rate of 4m a week from 22 March based on scenarios “commissioned by Cabinet Office” – although a second, more conservative forecast, suggests 4m a week could be hit by 25 April.

A little over a week ago, with average vaccination rates running at more than 400,000 a day, the UK hit a target to provide a vaccine to the 15 million people in the first four priority groups. Paul Hunter, a professor in medicine at the University of East Anglia, said: “Maybe they used up a lot more doses in the first part of February to make the self-imposed target and to look good.”

Dr Michael Head, a senior research fellow in global health at the University of Southampton, said it was too soon to tell if there were any serious problems. “We probably need another week of data to have a clearer picture around whether this is a concerning trend, or indeed part of natural fluctuations,” he said.

Sturgeon said Scotland would follow an announcement made by England over the weekend to bring forward a target to reach all people in the first nine priority groups by 15 April instead of 30 April.

That would mean everybody over 50 being offered a first shot shortly after Easter, as well as those with underlying health conditions plus health and care workers – a total of 32 million people across the UK. A rolling programme of second jabs in large numbers would also have begun by then.

HDA UK Media and Political Bulletin – 24 February 2021

From Factory to Pharmacy

As part of our mission to build awareness, understanding and appreciation of the vital importance of the healthcare distribution sector, we developed an infographic explaining the availability of medicines. It identifies the factors that can impact drug supply, as well as the measures that HDA members undertake day in, day out to help mitigate the risks of patients not receiving their medicines.

See the Infographic

Apply to become a Member

Membership of the HDA guarantees your organisation:

  • Access to leading policy and industry forums of debate and discussion
  • Invitations to a range of networking industry events organised through the year, including an Annual Conference and a Business Day
  • Representation on HDA working parties, including the Members’ Liaison Group
  • A daily Political and Media Bulletin and HDA Newsletters
  • Access to HDA policy documents and all sections of the HDA website
  • Branding and marketing opportunities
Apply Now

Already a Member?